Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Wilson
K. Wilson
The Hertz Corporation
Oral administration
Chemistry
Internal medicine
Endocrinology
Tumor necrosis factor alpha
2
Papers
170
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase.
2002
Journal of Pharmacology and Experimental Therapeutics
G. Beck
G. Bottomley
D. Bradshaw
M. Brewster
Michael J. Broadhurst
R. Devos
Christopher H. Hill
William Henry Johnson
H. J. Kim
Stephen J. Kirtland
J Kneer
N. Lad
R. Mackenzie
Robert C. G. Martin
John S. Nixon
G. Price
A Rodwell
F. Rose
J.P. Tang
Daryl Simon Walter
K. Wilson
E. Worth
Show All
Source
Cite
Save
Citations (52)
Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo
1997
British Journal of Pharmacology
E.J. Lewis
J. Bishop
Kevin M. K. Bottomley
David Bradshaw
M. Brewster
Michael J. Broadhurst
Paul Anthony Brown
J. M. Budd
Lucy H. Elliott
A. K. Greenham
William Henry Johnson
John S. Nixon
F. Rose
B.M. Sutton
K. Wilson
Show All
Source
Cite
Save
Citations (118)
1